HIGHLIGHTS
- who: Arshad Khan from the Estado de Jalisco (CIATEJ), Mexico James Cook University, Australia have published the article: NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice, in the Journal: (JOURNAL)
- what: Mouse models of vaccination used in this study have been previously described in detail . This study shows that SMNH adjuvant activation has a similar effect on BCG Pasteur vaccine. Safer adjuvants like alum are already in use during infant vaccination, and in this study, the authors sought to determine whether the efficacy of the infant BCG . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.